MannKind Assigned Patent

ALEXANDRIA, Va., Nov. 23 -- MannKind, Valencia, Calif., has been assigned a patent (8,314,106) developed by Kelly Sullivan Kraft, Hopewell Junction, N.Y., for "substituted diketopiperazine analogs for use as drug delivery agents."

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are drug delivery systems for the delivery of small molecule and macromolecular drugs. More particularly, disclosed are substituted analogs of 3,6-di(alkyl-4 aminobutyl)-2,5-diketopiperazine (which may also be referred to DKP), their use in the formulation of both small molecule and macromolecular drugs including therapeutic, prophylactic and diagnostic agents, stabilizing agents and systems for their delivery."

The patent application was filed on Dec. 29, 2009 (12/649,210). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,314,106&OS=8,314,106&RS=8,314,106

Written by Neha Bharti; edited by Jaya Anand.

http://www.equities.com/news/headline-story?dt=2012-11-23&val=750430&cat=hcare